NowFoods glucosamine, chondroitin subpotency error
This article was originally published in The Tan Sheet
Executive Summary
Supplement manufacturer will clarify labeling after confusion regarding potency of Now Double Strength Glucosamine & Chondroitin and Now Chondroitin Sulfate caused Consumer Reports to incorrectly list supplements as subpotent in its January issue, company says (1"The Tan Sheet" Dec. 17, 2001, p. 18). NowFoods President/CEO Elwood Richard sent Dec. 14 letter to CR detailing the error, and in early December CR's analytical laboratory director confirmed firm's assertion, NowFoods says. Company's Web site currently displays Jan. 10 letter to customers explaining error's resolution...
You may also be interested in...
Dietary Supplement Tax Reform Bill Complements CAM Commission Efforts
Legislation introduced by Rep. Dan Burton (R-Ind.) Dec. 12 would make the cost of dietary supplements, medical foods and foods for special dietary use tax-deductible for employers and excluded from taxable income for employees
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.